Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioxen is a pharmaceutical company based in Turkey that specializes in the development, manufacturing, and marketing of generic drugs, food supplements, and dermo-cosmetic products. The company is most recognized for its flagship brand of naproxen sodium, marketed under the name Bioxen, which is widely used for pain management and anti-inflammatory treatment. Beyond its core pharmaceutical portfolio, Bioxen offers an extensive range of over-the-counter (OTC) nutritional supplements, including vitamins, minerals, and collagen-based products. Operating from its headquarters and production facilities in Istanbul, the company adheres to international quality standards to serve both the domestic Turkish market and various export regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioxen.